Skip to content
← Holders

Foresite Capital Management VI LLC

What Foresite Capital Management VI LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 2013341 · Filed Nov 16, 2026

Positions
22
Reported value
$566.4M
Opened
4
Closed
5
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$258.9M
    12 positions
  2. Dec 31, 2025$330.8M
    12 positions
  3. Mar 31, 2026$460.3M
    17 positions
  4. Jun 30, 2026$642.6M
    23 positions
  5. Sep 30, 2026$566.4M
    22 positions
SecuritySharesChangeValueOf portfolio
CGONCG Oncology, Inc.
2.1M−11.0%$149.5M26.4%
KRSAKorsana Biosciences, Inc.
1.4MNew$45.8M8.1%
LTGOLatigo Biotherapeutics, Inc.
2.2MNew$36.8M6.5%
SPTXSeaport Therapeutics, Inc.
1.8M±0%$35.9M6.3%
DNLIDenali Therapeutics Inc.
1.6M+15.8%$33.4M5.9%
PBLSParabilis Medicines, Inc.
999K±0%$32.3M5.7%
ALMSAlumis Inc.
4.2M±0%$31.4M5.5%
AGIOAgios Pharmaceuticals, Inc.
827.1K+5.4%$27.5M4.9%
VSTMVerastem, Inc.
3.1M±0%$25.3M4.5%
GHRSGH Research PLC
940.5K±0%$22.1M3.9%
CRVSCorvus Pharmaceuticals, Inc.
1.8M±0%$21.1M3.7%
KYMRKymera Therapeutics, Inc.
146.3K±0%$16.4M2.9%
AVBPArriVent BioPharma, Inc.
490.3K+62.7%$14.8M2.6%
OBXObsidian Therapeutics, Inc.
916.1KNew$12.6M2.2%
JBIOJade Biosciences, Inc.
886.7K±0%$12.5M2.2%
HNGEHinge Health, Inc.
108.1K−51.0%$10.5M1.9%
AURAAura Biosciences, Inc.
1.3M±0%$8.4M1.5%
BEAMBeam Therapeutics Inc.
330K±0%$8.1M1.4%
ZURAZura Bio Ltd
1.8M+290.4%$7.3M1.3%
NERVMinerva Neurosciences, Inc.
2M±0%$6.7M1.2%
IRONDisc Medicine, Inc.
68.5K+6,958.8%$4.5M0.8%
ENTXEntera Bio Ltd.
1.2MNew$3.6M0.6%